openPR Logo
Press release

Bronchiectasis Therapeutics Pipeline - Key Players Analysis Aradigm Corporation, Bayer, Zambon

11-30-2018 08:54 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Bronchiectasis Therapeutics Pipeline - Key Players Analysis

The study analysed that the Bronchiectasis therapeutics pipeline comprises approximately 13 drug candidates in different stages of development.

Bronchiectasis is a condition in which damage to the airways causes them to widen and become flabby and scarred. The airways are tubes that carry air in and out of lungs. Bronchiectasis usually is the result of an infection or other condition that injures the walls of airways or prevents the airways from clearing mucus. In bronchiectasis, the airways slowly lose their ability to clear out mucus. When mucus cannot be cleared, it builds up and creates an environment in which bacteria can grow. This leads to frequent and serious lung infections.

Download report sample at: https://www.psmarketresearch.com/market-analysis/bronchiectasis-therapeutics-pipeline-analysis/report-sample

*Synthetic sources being used for the development of drugs

The research also found that there are several companies that use synthetic sources for the development of drugs for the treatment of bronchiectasis.

Some of the other key players developing drugs for the treatment of bronchiectasis include Aradigm Corporation, Bayer AG, Zambon SpA and others.

Browse Report at: https://www.psmarketresearch.com/market-analysis/bronchiectasis-therapeutics-pipeline-analysis

*Various technology platform for bronchiectasis drug development

Insmed’s liposomal technology is designed specifically for the delivery of pharmaceuticals to the lung. Liposomes are the microscopic membrane shells that contain water. In a liposome drug delivery system, water-soluble drugs such as amikacin, are located in the liposome’s water core. The liposome delivery system delivers medicine directly to the site of the lung infection. The infecting bacteria invade and multiply mainly within macrophages. The materials found in a patient’s mucus and biofilms that are produced by bacteria to protect themselves have negative charges which attracts opposite charged antibiotics such as amikacin.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bronchiectasis Therapeutics Pipeline - Key Players Analysis Aradigm Corporation, Bayer, Zambon here

News-ID: 1411650 • Views:

More Releases from P&S Intelligence

Remote Access Provided by Cloud Category Fuels Call Center AI Market
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media. In order to pace up the 4th industrial revolution, businesses across various industries
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Market
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Marke …
The total value of the customer engagement solutions market was $18,186.8 million in 2021, and it will rise at a growth rate of above 10% in the near future, to reach $43,398.9 million by 2030. The major reasons behind the growth of this industry are growing usage of such solutions in serval industries like healthcare, telecommunications, BFSI and FMCG. North America will grow the fastest with a rate of 10.5% in
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Market
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Marke …
The motion control market generated a revenue of $14,887.5 million in 2021, and it is expected to contribute $23,286.4 million in 2030, progressing at a rate of 5.1% from 2021 to 2030, ascribed to the rising demand for industrial robots and integration of components with the motion control systems for convenient use. Moreover, the evolving motion control standards and protocols propel the market, for example, the OPC UA TSN protocol controls
North America, the Largest Revenue Producer in Public Safety and Security Market
North America, the Largest Revenue Producer in Public Safety and Security Market
The size of the public safety and security market was at $411 billion in the year 2021, which will reach over $1,115 billion by the year 2030, advancing at a growth rate of around 12% in the years to come. This is largely ascribed to the rising application of innovative technologies in smart cities, increasing crime rates, the increasing cases of disastrous accidents, and the growing count of terrorist activities

All 5 Releases


More Releases for Bronchiectasis

Bronchiectasis Global Market Research Report 2025
Bronchiectasis Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/bronchiectasis-market/80987 The report firstly introduced the Bronchiectasis basics: definitions, classifications, applications and market overview; product
Bronchiectasis - Market Insights, Epidemiology and Market Forecast 2018-2027
Bronchiectasis Market: WiseGuyReports.com adds “Bronchiectasis Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2027” reports tits database. Executive Summary “Bronchiectasis - Market Insights, Epidemiology and Market Forecast – 2027” report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology. It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market
Bronchiectasis Therapeutics Analysis - Clinical Trials & Results, Collaboration …
The study analysed that the Bronchiectasis therapeutics pipeline comprises approximately 13 drug candidates in different stages of development. Bronchiectasis is a condition in which damage to the airways causes them to widen and become flabby and scarred. The airways are tubes that carry air in and out of lungs. Bronchiectasis usually is the result of an infection or other condition that injures the walls of airways or prevents the airways
Bronchiectasis Market To Discern Magnified Growth During 2025
Bronchiectasis is a chronic and life-threatening disease, wherein parts of airways of lungs are permanently enlarged. This condition damages the bronchial tubes of lungs permanently and also widens, and thickens them. Inflammation and infection in the bronchi leads to this condition. The severity of bronchiectasis symptoms may vary widely. The most common symptom of bronchiectasis is breathlessness i.e., difficulty in breathing or feeling short of breath, frequent chest infections, and
Bronchiectasis Treatment Market Foraying into Emerging Economies 2017 - 2025
Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in serious health conditions such as heart failure and respiratory failure. Mucus producing cough is the major symptom of this condition. Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/21037
Bronchiectasis Therapeutics Clinical Trials, Pipeline Analysis & Collaboration
Bronchiectasis is a condition in which damage to the airways causes them to widen and become flabby and scarred. The airways are tubes that carry air in and out of lungs. Bronchiectasis usually is the result of an infection or other condition that injures the walls of airways or prevents the airways from clearing mucus. In bronchiectasis, the airways slowly lose their ability to clear out mucus. When mucus cannot